The AJMC® Parkinson Disease compendium is a comprehensive resource for clinical news and expert insights for progressive nervous system disorder, which affects movement and often includes tremors.
February 26th 2025
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
Noncontact Boxing Workout Improves QOL, Workout Adherence
March 17th 2020A special, noncontact boxing program was shown to potentially improve quality-of-life (QOL) and likelihood of exercise among patients with Parkinson disease compared with those who did not participate, according to preliminary study findings originally to be presented at the American Academy of Neurology’s 72nd Annual Meeting.
Read More
Patients With Parkinson Disease at Increased Risk of Vision, Eye Issues, Study Shows
March 12th 2020Patients with Parkinson disease were found to be more likely to experience vision and eye issues, such as blurry vision, dry eyes, trouble with depth perception, and problems adjusting to rapid changes in light, compared with people without the disorder, according to study findings.
Read More
Motor and Non-Motor Wearing-off Impact Quality of Life in Parkinson, Study Finds
March 2nd 2020A recent study aiming to evaluate the impact of motor and non-motor wearing-off—a common phenomenon in Parkinson disease (PD)—found that the fluctuations have an impact on the activities of daily living and quality of life, with non-motor wearing-off having the greater impact.
Read More
Study Finds Tai Chi Exercises May Prove Effective for Patients With Parkinson Disease
February 29th 2020In individuals with mild to moderate Parkinson disease, Tai Chi was shown to be a potentially effective meditation technique that may slow down disease progression, according to study findings.
Read More
Study Suggests Table Tennis Exercises May Benefit Motor Symptoms in Parkinson Disease
February 26th 2020In a preliminary study to be presented at the American Academy of Neurology’s 72nd Annual Meeting, researchers found that patients with Parkinson disease who participated in a table tennis exercise program once a week for 6 months exhibited an improvement in their motor skills.
Read More
Adherence Suffers When OOP Drug Costs for Neurologic Disorders Rise, Study Shows
February 20th 2020Higher out-of-pocket (OOP) drug costs for 3 common neurologic conditions—Parkinson disease, Alzheimer disease, and peripheral neuropathy—were associated with lower medication adherence among patients, which can potentially intensify symptom burden and result in higher costs.
Read More
Results: White Matter Hyperintensities Can Be Predictive Marker in Early Stage Parkinson Disease
February 17th 2020These findings suggest that baseline white matter hyperintensities can act as a predictive marker or therapeutic target for the development of levodopa-induced dyskinesia in patients with early stage Parkinson disease.
Read More
Palliative Care Improves Quality of Life, Symptom Burden of Patients With Parkinson Disease
February 11th 2020Compared with standard care, patients with Parkinson disease and related disorders who received palliative care exhibited improved quality of life and better symptom burden at 6 months after intervention, according to study findings.
Read More
Novel Technology Found to Distinguish Between Parkinson Disease, Multiple System Atrophy
February 5th 2020A novel protein misfolding cyclic amplification technology was able to distinguish between 2 progressive neurodegenerative diseases, Parkinson disease (PD) and multiple system atrophy, signaling potential improvements in diagnosis of PD.
Read More
This Week in Managed Care: January 10, 2020
January 10th 2020This week, the top managed care stories included cancer deaths falling for the 25th straight year; a study finding no link between talc powder and ovarian cancer; a poll finding 1 in 4 patients with Parkinson disease may be misdiagnosed.
Watch
Poll Finds 1 in 4 People With Parkinson Disease Misdiagnosed
January 8th 2020In a poll of people with Parkinson disease, more than 1 in 4 (26%) participants reported having been misdiagnosed, with a further 21% having to see their general provider 3 times before being referred to a specialist.
Read More
Study Targets Cannabinoid Receptor to Ease Parkinson Symptom of Dyskinesia
December 21st 2019The drug, HU-308, is aimed at treating levodopa-induced dyskinesia (LID). The animal study showed that it was as effective as amantadine, the only available treatment for dyskinesias; combining HU-308 with amantadine was also more effective than either drug used alone.
Read More
Caregivers of patients with Parkinson disease (PD) experiencing symptom recurrence after a period of symptom control, known as OFF periods, reported that PD had a greater impact on their paid employment through variables such as loss of earnings, loss of opportunities, or ability to maintain employment compared with caregivers for patients without OFF periods.
Read More
Symptom Control of Parkinson Disease Linked to Ability, Productivity of Employment
December 15th 2019Study results presented at AMCP Nexus 2019 in National Harbor, Maryland, showed that 65.4% of patients with parkinson disease reported experiencing symptom recurrence, known as OFF periods, which impedes work productivity and employment.
Read More
Study Probes Key Receptor Signaling That Goes Awry in Parkinson
December 13th 2019Dopamine receptor D3 (DRD3) signaling regulates the dynamic of the acquisition of pro-inflammatory and anti-inflammatory features by astrocytes and microglia, favoring microglial activation and promoting neuroinflammation—the pathogenic process leading to neurodegeneration in many disorders, including Parkinson disease, according to a recent study.
Read More
Altered Emotional Capability Possibly Linked to Atypical Form of Parkinson
December 7th 2019Alexithymia—the inability of recognizing and verbalizing emotions and distinguishing them from bodily sensations—may be identifiable early on in patients with progressive supranuclear palsy with predominant parkinsonism (PSP-P) and PSP with Richardson’s syndrome (PSP-RS).
Read More
Study Looks at Biomarker for Parkinson Disease
November 30th 2019A study aiming to determine whether blood cells expressing α‐synuclein (α‐syn) can differentiate Parkinson disease (PD) from healthy controls (HC), finding that there is potential usefulness of blood cells expressing α‐syn as a biomarker for PD.
Read More
Minimally Invasive Procedure Reduces Tremors in Patients With Parkinson Disease
November 26th 2019A minimally invasive procedure that applies pulses of focused ultrasound to the brain was found to be safe and effective in reducing tremors and improving the quality of life in patients with Parkinson disease and essential tremor, according to research to be presented at the annual meeting of the Radiological Society of North America.
Read More
New Molecular Drivers of Parkinson Disease Discovered, Indicating Potential Treatment Innovations
November 21st 2019Researchers discovered new molecular drivers of Parkinson disease (PD) and determined their impact on the functions of genes involved in PD, potentially leading to novel treatments, according to study findings.
Read More
Game System May Be Effective Rehabilitation Option for Parkinson Disease, Study Finds
November 15th 2019The Leap Motion Controller system used with serious games may be an effective option for a rehabilitation tool for improving coordination, speed of movements, and fine upper limb dexterity in patients with Parkinson disease, according to a recent study, published by the Journal of NeuroEngineering and Rehabilitation.
Read More
EPA Proposal to Limit Science Used in Rulemaking Takes Center Stage During Committee Meeting
November 14th 2019The EPA proposal to limit science used in rulemaking was discussed by panel members during a hearing held today by the House Committee on Science, Space, and Technology, with patient confidentiality serving as a major issue.
Read More